Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Elizabeth J Beckman

11PUBLICATIONS
14CO-AUTHORS
Traditional Chinese medicine and treatmentsInfant and child healthCounselling psychologyCardiology (incl. cardiovascular diseases)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

Sort by Publication Date:
|May 14, 2025
Crushing Elexacaftor/Tezacaftor/Ivacaftor Oral Granules for Gastrostomy Tube Administration.

Alexander S Kim, Elizabeth Autry

|Mar 27, 2024
Vancomycin AUC<sub>0-24</sub> estimation using first-order pharmacokinetic methods in pediatric patients.

Hope H Brandon, David S Burgess, Katie L Wallace

|Dec 05, 2023
A decade of change: The evolution of pharmacy services at U.S. cystic fibrosis centers.

Paige M Grube, Elizabeth B Autry, Lauren N Kormelink

|Nov 29, 2023
Assessment of long-term medication adherence with cystic fibrosis: An integrated approach.

Thomas Platt, Lauren N Kormelink, Elizabeth B Autry

|Oct 07, 2022
Retrospective review of vancomycin monitoring via trough only versus two-point estimated area under the curve in pediatric and adult patients with cystic fibrosis.

Billie Mitchell, Lauren Kormelink, Robert Kuhn

|Dec 01, 2021
The use of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis postliver transplant: A case series.

Hunter Ragan, Elizabeth Autry, Taryn Bomersback

Pageof 2

Frequent Collaborators

3 joint publications

Robert J Kuhn

2 joint publications

David C Young

2 joint publications

Jeffery T Zobell

2 joint publications

Lauren N Kormelink

1 joint publications

Alexander Patterson

1 joint publications

Mark Wurth

1 joint publications

Lisa Lubsch

1 joint publications

Alexander S Kim

1 joint publications

Kelsey Leonhardt

1 joint publications

Paige M Grube

Frequent Collaborators

3 joint publications

Robert J Kuhn

2 joint publications

David C Young

2 joint publications

Jeffery T Zobell

2 joint publications

Lauren N Kormelink

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

8.2K
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on : Mar 03, 2023

1.4K
Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on : Apr 11, 2018

10.7K
See more related videos

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

8.2K
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on : Mar 03, 2023

1.4K
Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on : Apr 11, 2018

10.7K
See more related videos